Distinguishing True Restenosis from Coronary Vasospasm Post-Stent
Use intravascular imaging with OCT or IVUS to definitively differentiate true in-stent restenosis from coronary vasospasm—OCT will show neointimal hyperplasia or neoatherosclerosis in restenosis versus smooth vessel narrowing in spasm, and perform intracoronary provocation testing (acetylcholine or ergonovine) if vasospasm is suspected. 1
Diagnostic Algorithm
Step 1: Clinical Context Assessment
At 8 months post-stent, you're in the typical window for both phenomena:
- In-stent restenosis (ISR) occurs in 17-32% of patients with bare metal stents and 5-10% with drug-eluting stents 2, 3
- Timing matters: Restenosis presenting <3 months suggests aggressive neointimal hyperplasia; 6-12 months is the peak window for ISR 2
- LAD location increases restenosis risk (OR 3.0) 2
Step 2: Symptom Pattern Analysis
Restenosis typically presents with:
- Progressive, exertional angina
- Predictable symptom threshold
- Gradual onset over weeks
Vasospasm typically presents with:
- Rest angina, often nocturnal or early morning
- Unpredictable episodes
- Rapid symptom resolution (minutes)
- ST-segment elevation during pain 4, 5
Step 3: Mandatory Intravascular Imaging
This is non-negotiable for accurate diagnosis 1:
OCT findings in true restenosis:
- Neointimal tissue within stent (hyperplasia appears homogeneous, bright)
- Neoatherosclerosis (lipid-laden tissue, thin-cap fibroatheroma)
- Stent underexpansion or malapposition
- Tissue prolapse between struts 1, 3
OCT findings in vasospasm:
- Smooth luminal narrowing without tissue proliferation
- Normal vessel wall architecture
- Reversible with intracoronary nitrates
- No neointimal tissue accumulation 4
IVUS findings in restenosis:
- Tissue growth uniformly distributed throughout stent
- Smaller post-procedure minimum lumen diameter predicts restenosis 2
Step 4: Provocative Testing for Vasospasm
If imaging suggests spasm or symptoms are atypical:
- Perform intracoronary acetylcholine provocation test (20-200 mcg incremental doses)
- Positive test: >90% vasoconstriction with chest pain and ECG changes 6, 7
- Critical caveat: Only perform provocation testing AFTER confirming no significant fixed stenosis on imaging, as it can trigger vessel closure in dissection 1
Key Differentiating Features
Angiographic Clues (Before Imaging)
- Restenosis: Focal narrowing at stent edges or diffuse in-stent narrowing, fixed pattern on multiple views
- Vasospasm: May appear severe but shows variation between injections, responds dramatically to nitrates, can occur adjacent to but not within stented segment 6, 7
Important Pitfall
Vasospasm can occur OUTSIDE the stented segment while the stent itself remains patent—acetylcholine provocation in one case showed spasm in all areas except the stented segment 6. Don't assume symptoms are from the stent location.
Management Implications Based on Diagnosis
If True Restenosis Confirmed:
- Drug-eluting stent implantation (Class I recommendation) 3
- Drug-coated balloon for focal patterns
- Consider CABG for recurrent diffuse ISR 3
If Vasospasm Confirmed:
- Intensify vasodilator therapy: calcium channel blockers (diltiazem, benidipine) + long-acting nitrates + nicorandil 4
- Avoid stenting for pure vasospasm—it doesn't prevent spasm and adds restenosis risk 7
- Verify spasm control with repeat provocation testing under vasodilator therapy 4
If Both Coexist:
This scenario occurs and is particularly challenging 4, 5:
- Treat fixed stenosis with PCI
- Aggressively manage vasospasm medically
- Close follow-up as vasospasm may contribute to progressive stenosis 4
The 57% Pre-Stent Lesion Context
The original 57% stenosis was borderline for intervention. Consider whether: